Depression News and Research

Latest Depression News and Research

Self-care tips for hemorrhoids from Mayo Clinic

By about age 50, more than half of adults have dealt with hemorrhoids. The November issue of Mayo Clinic Health Letter covers home treatments that can relieve symptoms of this common and embarrassing problem.

16 Nov 2009

HealthPartners' health plans ranked top in Minnesota

HealthPartners is among the top 25 best private health plans in the nation and the top ranked plan in Minnesota according to U.S. News & World Report/NCQA “America's Best Health Insurance Plans 2009-10.” The report measures how well health plans perform on 50 measures of health care and member satisfaction. Two hundred thirty nine health plans from across the nation are included in the report. The top 50 health plans, including HealthPartners, are listed in the Nov. 16, 2009 print edition of U.S. News & World Report.

16 Nov 2009

Findings from post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse announced

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse-. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.

16 Nov 2009

Chronic pain patients with depression three times more likely to receive opioid medications

Chronic pain patients with a history of depression are three times more likely to receive long-term prescriptions for opioid medications like Vicodin compared to pain patients who do not suffer from depression, according to new research.

16 Nov 2009

Poor mental health in children and teenagers impacts on the length of time they will stay in school: Study

"Our study shows that poor mental health in children and teenagers has a large impact on the length of time they will stay in school," says Dr. Lehrer. He notes a large number of school-based programs have recently been introduced to prevent childhood obesity through lifestyle changes, but suggests the net should be cast more widely. "It's important for policymakers to target health conditions that are not the easiest to identify - like inattention - but may have larger impacts on one's future."

13 Nov 2009

Shire announces findings from Phase 3 study data with Vyvanse

Shire plc, the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.

13 Nov 2009

PKCI/HINT1 gene associated with mood regulation

Removing the PKCI/HINT1 gene from mice has an anti-depressant-like and anxiolytic-like effect. Researchers writing in the open access journal BMC Neuroscience applied a battery of behavioral tests to the PKCI/HINT1 knockout animals, concluding that the deleted gene may have an important role in mood regulation.

13 Nov 2009

Health Canada approves ONGLYZA for type 2 diabetes treatment

Bristol-Myers Squibb Canada and AstraZeneca Canada today announced that Health Canada has approved ONGLYZA(TM) (saxagliptin) which improves all three key measures of glycemic control - hemoglobin A1c (A1c), fasting plasma glucose (FPG) and post-prandial glucose (PPG) - when taken in combination with other commonly used oral anti-diabetic agents (metformin or a sulfonylurea).

13 Nov 2009

New and effective medicines underway for treating a wide range of diseases affecting women

Women's Health Weekly recently reported that America's pharmaceutical research and biotechnology companies are working on nearly 1,000 life-changing medicines for diseases affecting women, according to a new report released by the Pharmaceutical Research and Manufacturers of America (PhRMA). The medicines are awaiting approval by the U.S. Food and Drug Administration or are in human clinical trials.

13 Nov 2009

Results from an analysis emphasizes the financial burden of SMI on the criminal justice and HHS systems

Results from a large, retrospective analysis of inmates with a serious mental illness (SMI) underscores the financial burden of mental illness on the criminal justice and health and human services (HHS) systems, and may provide useful information to policy makers.

12 Nov 2009

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Malfunctioning circadian clock genes may be responsible for bipolar disorder in children. Researchers writing in the open access journal BMC Psychiatry found four versions of the regulatory gene RORB that were associated with pediatric bipolar disorder.

11 Nov 2009

Post-traumatic stress disorder among veterans on the rise, reveals survey

Recent survey results reveal that the prevalence of post-traumatic stress disorder (PTSD) has increased 4 to 7 times following the invasion of Iraq.

11 Nov 2009

Online patient support program for ADHD patients taking Vyvanse Capsules CII medication

Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced the re-launch of FOCUS (http://www.vyvanseFOCUS.com), a free, online patient support program for adults taking once-daily Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD), and the only online, branded personalized patient support program providing tips and tools for adults diagnosed with ADHD taking a prescription medication.

11 Nov 2009

Two VA employees lose their lives in Ft. Hood shooting

In the midst of providing mental health services and other support to the Ft. Hood community following the recent shooting, the Department of Veterans Affairs (VA) learned about its own losses from the violence. Two VA employees, both serving on active duty with their Army Reserve units, were among the slain. A third VA health care worker on reserve duty was seriously wounded.

11 Nov 2009

Potential benefits of Labopharm's novel trazodone formulation published

Labopharm Inc. today announced an article has been published in the international journal of neuropsychiatric medicine, CNS Spectrums October, 2009 issue, citing the potential benefit of its novel trazodone formulation, which contains Contramid(R). Labopharm's Contramid is the clinically validated proprietary technology that controls the release of active substances from oral medications to optimize drug delivery.

11 Nov 2009

Sports team participation increases unhealthy behaviors in teenage boys

Contradicting what most parents might think, participation in team sports doesn't necessarily result in teenage boys adopting healthier behaviors. Instead, new research finds that it is actually associated with increased fighting and drinking.

11 Nov 2009

Women face higher risk of post-stroke depression

Depression occurs in as many as one-third of patients after a stroke, and women are at somewhat higher risk, according to a large new review of studies. Post-stroke depression is associated with greater disability, reduced quality of life and an increased risk of death.

11 Nov 2009

Avanir Pharmaceuticals unveils Star trial results for Zenvia in the treatment of PBA

AVANIR Pharmaceuticals, Inc. today announced efficacy, safety and tolerability results from the 12-week open-label extension phase of the confirmatory Phase III STAR trial evaluating the investigational drug Zenvia™ (dextromethorphan/quinidine) in the treatment of patients with pseudobulbar affect (PBA).

11 Nov 2009

NEDA supports Real Women campaign, an initiative which condemns the use of ultra-thin women in advertisements

The National Eating Disorders Association (NEDA) has joined leading experts on body image issues from around the world to pledge its support of the global launch of the Real Women campaign, which condemns the use of ultra-thin, digitally altered women in advertisements.

10 Nov 2009

Groundbreaking technologies and design innovations can improve older people's quality of life

A 2,600 foot model home unveiled today transforms the idea of aging in place by using groundbreaking technologies and design innovations that make it possible for more older adults to remain independent and at home for longer. This one-of-a-kind home is on display at McCormick Place in Chicago as part of the American Association of Homes and Services for the Aging's (AAHSA) Annual Meeting & Exposition from November 9-11.

10 Nov 2009

Depression News and Research

Latest Depression News and Research

Self-care tips for hemorrhoids from Mayo Clinic

HealthPartners' health plans ranked top in Minnesota

Findings from post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse announced

Chronic pain patients with depression three times more likely to receive opioid medications

Poor mental health in children and teenagers impacts on the length of time they will stay in school: Study

Shire announces findings from Phase 3 study data with Vyvanse

PKCI/HINT1 gene associated with mood regulation

Health Canada approves ONGLYZA for type 2 diabetes treatment

New and effective medicines underway for treating a wide range of diseases affecting women

Results from an analysis emphasizes the financial burden of SMI on the criminal justice and HHS systems

Malfunctioning circadian clock genes may be associated with bipolar disorder in children

Post-traumatic stress disorder among veterans on the rise, reveals survey

Online patient support program for ADHD patients taking Vyvanse Capsules CII medication

Two VA employees lose their lives in Ft. Hood shooting

Potential benefits of Labopharm's novel trazodone formulation published

Sports team participation increases unhealthy behaviors in teenage boys

Women face higher risk of post-stroke depression

Avanir Pharmaceuticals unveils Star trial results for Zenvia in the treatment of PBA

NEDA supports Real Women campaign, an initiative which condemns the use of ultra-thin women in advertisements

Groundbreaking technologies and design innovations can improve older people's quality of life

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Depression News and Research

Latest Depression News and Research

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Newsletters you may be interested in